Pacific Biosciences Of California (PACB) Current Deferred Revenue (2010 - 2026)
Pacific Biosciences Of California's quarterly Current Deferred Revenue came in at $16.3 million in Q1 2026, up 7.15% year-on-year from $15.2 million in Q1 2025, and up 2.47% quarter-over-quarter from $15.9 million in Q4 2025.
Pacific Biosciences Of California has reported Current Deferred Revenue for 17 years, with the latest figure at $16.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue rose 7.15% year-over-year to $16.3 million; the trailing twelve-month figure through Mar 2026 stood at $16.3 million (up 7.15% YoY), and the FY2025 full-year result was $15.9 million, up 14.95% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $16.3 million, up from $15.9 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $32.1 million in Q2 2022, with the low at $12.7 million in Q1 2022.
- Average Current Deferred Revenue over 5 years is $21.0 million, with a median of $17.3 million recorded in 2024.
- Year-over-year, Current Deferred Revenue surged 236.52% in 2022 and slumped 46.42% in 2023.
- Tracing PACB's Current Deferred Revenue over 5 years: stood at $30.5 million in 2022, then tumbled by 46.42% to $16.3 million in 2023, then slipped by 15.16% to $13.9 million in 2024, then gained by 14.95% to $15.9 million in 2025, then gained by 2.47% to $16.3 million in 2026.
- The last three Current Deferred Revenue figures came in at $16.3 million (Q1 2026), $15.9 million (Q4 2025), and $16.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.33 Mn |
| Dec 31, 2025 | 15.94 Mn |
| Sep 30, 2025 | 16.05 Mn |
| Jun 30, 2025 | 14.86 Mn |
| Mar 31, 2025 | 15.24 Mn |
| Dec 31, 2024 | 13.86 Mn |
| Sep 30, 2024 | 17.29 Mn |
| Jun 30, 2024 | 19.21 Mn |
| Mar 31, 2024 | 23.40 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | 22.40 Mn |
| Jun 30, 2023 | 30.00 Mn |
| Mar 31, 2023 | 30.87 Mn |
| Dec 31, 2022 | 30.50 Mn |
| Sep 30, 2022 | 30.69 Mn |
| Jun 30, 2022 | 32.08 Mn |
| Mar 31, 2022 | 12.73 Mn |
| Dec 31, 2021 | 10.98 Mn |
| Jun 30, 2021 | 9.53 Mn |
| Mar 31, 2021 | 9.61 Mn |
| Dec 31, 2020 | 8.72 Mn |
| Sep 30, 2020 | 6.98 Mn |
| Jun 30, 2020 | 6.93 Mn |
| Mar 31, 2020 | 7.11 Mn |
| Dec 31, 2019 | 7.60 Mn |
| Sep 30, 2019 | 6.38 Mn |
| Jun 30, 2019 | 6.71 Mn |
| Mar 31, 2019 | 6.43 Mn |
| Dec 31, 2018 | 6.54 Mn |
| Sep 30, 2018 | 5.74 Mn |
| Jun 30, 2018 | 6.42 Mn |
| Mar 31, 2018 | 5.99 Mn |
| Dec 31, 2017 | 6.32 Mn |
| Sep 30, 2017 | 6.15 Mn |
| Jun 30, 2017 | 6.78 Mn |
| Mar 31, 2017 | 6.68 Mn |
| Dec 31, 2016 | 7.13 Mn |
| Sep 30, 2016 | 6.44 Mn |
| Jun 30, 2016 | 6.97 Mn |
| Mar 31, 2016 | 6.37 Mn |
| Dec 31, 2015 | 6.82 Mn |
| Sep 30, 2015 | 6.30 Mn |
| Jun 30, 2015 | 6.51 Mn |
| Mar 31, 2015 | 6.25 Mn |
| Dec 31, 2014 | 6.12 Mn |
| Sep 30, 2014 | 5.31 Mn |
| Jun 30, 2014 | 5.27 Mn |
| Mar 31, 2014 | 3.90 Mn |
| Dec 31, 2013 | 4.05 Mn |
| Sep 30, 2013 | 10.36 Mn |
| Jun 30, 2013 | 3.35 Mn |
| Dec 31, 2012 | 3.38 Mn |
| Mar 31, 2012 | 3.92 Mn |
| Dec 31, 2011 | 4.24 Mn |
| Sep 30, 2011 | 3.97 Mn |
| Jun 30, 2011 | 2.38 Mn |
| Dec 31, 2010 | 3.22 Mn |